iifl-logo-icon 1

Tejnaksh Healthcare Ltd Company Summary

25.71
(3.17%)
Oct 11, 2024|03:40:00 PM

Tejnaksh Healthcare Ltd Summary

Tejnaksh Healthcare Limited was incorporated in February 18, 2008. The Company is engaged in provision of hospital and healthcare and pharmacy services in Mumbai and other parts of Maharashtra. The Company has one subsidiary company, Tej Vedaant Healthcare Private Limited. In innovations, the Company has more than 150 research papers, 23 innovations, 13 patents applied, multiple national and international awards and to top it off, have multiple records in the Guinness Book, Limca Book, Asia & Ripleys Book. Today, the Company takes pride in manufacturing and distribution of many patented products. Being one of the leading innovative healthcare providing brands in the country, the Company continues to fathom newer avenues, break through newer achievements and reach newer heights.Initiated with a vision to strengthen healthcare in rural India, the Company started its journey from Institute of Urology, a state of the art flagship, kidney care center in Dhule in the year 2003. The only healthcare IPO from the area and the speciality, the Company has been an ardent believer of high ethical and professional standards and focused on excellence in clinical services, diagnostic facilities and research. A recognized teaching institute by the Ministry of Health and Family welfare, the Company provides quality healthcare services at 13 urology clinics, 4 urology hospitals and 2 dental super specialty clinics. The Companys achievements were the multiple records that motivates the customers to improve treatment for Urology.The Company achieved the following milestones during the following years:In 2005, the Company started the 1st Urodynamics Lab of North Maharashtra.In 2006 , the Company established First Urology CME for the family physicians.In 2007, the Company set up 1st Laser Unit of North Maharashtra and 1st Flexible Ureteroscope of North Maharashtra.In 2008, the Company filed the 1st Innovation Patent. In 2009, the Company was into Urology and healthcare training, recognized by The National Board of Examination. In 2010, the Company was moved to the 1st Guinness World Record and established about 13 satellite centers.In 2011, the Company achieved the Records in Limca, Asia & Ripleys Book 2011 and Records in World Amazing Records, World Record Academy.In the same year, the company won the best research paper: Urological Society of India-WZ.In 2012, the Company won the S.S. Bapat prize for best innovation; it set up the First urology conference - Stonecon and hit the 2nd Guinness World Record.In 2013, the 5-PANG PCNL system became commercially available for the Company. The Company was won the S.S. Bapat Prize for Best Innovation during the year 2013.In 2014, the Company won the Second Guinness World Records. In the same year, the Company started first online opinion window for patients.In 2015, the Company hosted the first PCNL workshop and became a public limited company. During the same year, the Company first dental speciality clinic. It took the initiative to set up The International Health Tourism.In 2016, the Company set up the first indigenous PCNL simulation lab in the country. The PCNL simulators manufactured by Tejnaksh became commercially available during the year. The Company started Urology and Dental centers at Malegaon (MS), Sendhwa (MP) and a multi-speciality center in Navi Mumbai during the year.

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS

  • Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020
  • Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
  • Pay 20% upfront margin of the transaction value to trade in cash market segment.
  • Investors may please refer to the Exchange’s Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.
  • Check your Securities / MF / Bonds in the consolidated account statement issued by NSDL/CDSL every month.
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day.” – Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp